Will Medicare cover Wegovy (semaglutide) in 2025?
Medicare coverage for Wegovy in 2025 depends on whether the plan treats it as a covered Part D drug and whether it’s covered with any required prior authorization, quantity limits, or step therapy. The key point is that Medicare generally does not pay for weight-loss drugs under Part B, but many Medicare beneficiaries can get prescription coverage for specific drugs through Part D.
Whether Wegovy is covered on a specific Medicare Part D plan can vary by formulary and plan rules in 2025. Even if a drug is on the formulary, coverage may require documentation such as meeting the prescribing criteria for Wegovy (for example, certain BMI and weight-related conditions) and prior authorization.
What Medicare part typically pays for Wegovy?
Most coverage questions for Wegovy come down to prescription drug coverage (Medicare Part D), not Medicare Part A or Part B:
- Part B usually covers drugs given in specific clinical settings and generally does not cover prescription anti-obesity medications as a typical benefit.
- Part D covers many outpatient prescription drugs, but each plan’s formulary determines whether Wegovy is included and under what conditions.
How can you check if your plan will pay for Wegovy?
To find out if you will be able to get Wegovy covered in 2025, check your:
- Medicare Part D plan formulary (the plan’s list of covered drugs)
- Drug tier and expected cost-sharing
- Prior authorization requirements and criteria
- Step therapy rules (if applicable)
- Pharmacy network and quantity limits
If Wegovy is not on your plan’s formulary, your prescriber may be able to request an exception or prior authorization (if allowed), depending on your plan’s rules.
If Medicare doesn’t cover it, what options might still help?
If your plan does not cover Wegovy or places it behind strict prior authorization:
- Your prescriber can ask for a prior authorization/exception using the medical criteria the plan requires.
- You can ask about alternatives on your formulary (other anti-obesity medications, if covered).
- Patient assistance or manufacturer programs may be available, which can reduce out-of-pocket costs even when insurance coverage is limited.
Any updates worth watching for 2025?
Coverage rules and formularies can change each contract year, so even if Wegovy was covered in 2024, it may not be covered the same way in 2025 (or it may move tiers). Reviewing your 2025 formulary for your specific plan is the most reliable way to confirm.
If you tell me your state and whether you have Original Medicare with a Part D plan or a Medicare Advantage plan (with drug coverage), I can help you figure out the most likely path to coverage and what to ask your plan/doctor.
Sources: I don’t have enough provided information to cite a specific Medicare/Wegovy coverage decision for 2025 from DrugPatentWatch.com or other sources.